Live Breaking News & Updates on Stewarta Anderson

Stay updated with breaking news from Stewarta anderson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mitochondrial Dysfunction May Raise Schizophrenia Risk in 22q Patients


Mitochondrial Dysfunction May Raise Schizophrenia Risk in 22q Patients
A disorder called 22q11.2 deletion syndrome (22q) affects about one in 2,000 births, and causes dysfunction in every organ system including the heart and brain. It s been linked to behavioral changes including autism spectrum disorder, anxiety, and attention deficit hyperactive disorder. These problems may begin in adolescence and can persist in adults, when other psychiatric illnesses may emerge. Schizophrenia, for example, is about 25 times more likely in 22q patients.
Researchers have now learned more about a connection between an organelle known as the powerhouse of cells, the mitochondria, and the development of schizophrenia in 22q patients. The findings, which were reported in ....

United States , Stewarta Anderson , Donnam Mcdonald Mcginn , Douglasc Wallace , University Of Pennsylvania Penn , You Center , Behavioral Services , Department Of Child , Clinical Genetics Center , Lifespan Brain Institute , Perelman School Of Medicine , Adolescent Psychiatry , Perelman School , Epigenomic Medicine , Associate Director , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பென் , நீங்கள் மையம் , நடத்தை சேவைகள் , துறை ஆஃப் குழந்தை , ஆயுட்காலம் மூளை நிறுவனம் , பெரல்மேன் பள்ளி ஆஃப் மருந்து , பெரல்மேன் பள்ளி , இணை இயக்குனர் ,

Mitochondrial function influences schizophrenia status in patients with genetic disorder


 E-Mail
Philadelphia, May 19, 2021 - A multidisciplinary team of researchers from Children s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn) showed how the batteries of cells are highly implicated in whether patients with the chromosome 22q11.2 deletion syndrome develop schizophrenia. The results of the study may eventually lead to targeted prevention and treatment strategies for patients with the condition.
The findings were published today in
JAMA Psychiatry.
22q11.2 deletion syndrome (22q) is a chromosomal difference that occurs in approximately one out of every 2,000 births and is associated with varying degrees of medical issues affecting every system in the body, including the developing heart, immune system, palate, and brain. 22q is also associated with behavioral health challenges such as attention deficit hyperactive disorder, autism spectrum disorder and anxiety. These symptoms can be obser ....

United States , Stewarta Anderson , Donnam Mcdonald Mcginn , Douglasc Wallace , University Of Pennsylvania Penn , You Center , Behavioral Services , National Institutes Of Health , Clinical Genetics Center , Lifespan Brain Institute , Perelman School Of Medicine , Perelman School , Adolescent Psychiatry , Epigenomic Medicine , Associate Director , National Institutes , Mitochondrial Biogenesis With Variable Penetrance , Medicine Health , Mental Health , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பென் , நீங்கள் மையம் , நடத்தை சேவைகள் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , ஆயுட்காலம் மூளை நிறுவனம் , பெரல்மேன் பள்ளி ஆஃப் மருந்து ,